BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20962085)

  • 1. Novel F141L pre-S2 mutation in hepatitis B virus increases the risk of hepatocellular carcinoma in patients with chronic genotype C infections.
    Mun HS; Lee SA; Kim H; Hwang ES; Kook YH; Kim BJ
    J Virol; 2011 Jan; 85(1):123-32. PubMed ID: 20962085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
    Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
    J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis.
    Li TN; Wu YJ; Tsai HW; Sun CP; Wu YH; Wu HL; Pei YN; Lu KY; Yen TT; Chang CW; Chan HL; Tao MH; Liou JY; Chang MD; Su IJ; Wang LH
    J Pathol; 2018 Aug; 245(4):502-513. PubMed ID: 29862509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis.
    Wang HC; Huang W; Lai MD; Su IJ
    Cancer Sci; 2006 Aug; 97(8):683-8. PubMed ID: 16863502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus pre-S/S variants in liver diseases.
    Chen BF
    World J Gastroenterol; 2018 Apr; 24(14):1507-1520. PubMed ID: 29662289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma.
    Kao JH; Liu CJ; Jow GM; Chen PJ; Chen DS; Chen BF
    Liver Int; 2012 Oct; 32(9):1373-81. PubMed ID: 22676233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male-specific hepatitis B virus large surface protein variant W4P potentiates tumorigenicity and induces gender disparity.
    Lee SA; Kim H; Won YS; Seok SH; Na Y; Shin HB; Inn KS; Kim BJ
    Mol Cancer; 2015 Feb; 14(1):23. PubMed ID: 25645622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection.
    Choi MS; Kim DY; Lee DH; Lee JH; Koh KC; Paik SW; Rhee JC; Yoo BC
    J Viral Hepat; 2007 Mar; 14(3):161-8. PubMed ID: 17305881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B.
    Yeung P; Wong DK; Lai CL; Fung J; Seto WK; Yuen MF
    J Infect Dis; 2011 Mar; 203(5):646-54. PubMed ID: 21227916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice.
    Teng YC; Neo JC; Wu JC; Chen YF; Kao CH; Tsai TF
    J Pathol; 2017 Mar; 241(4):463-474. PubMed ID: 27868197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro.
    Salpini R; Surdo M; Warner N; Cortese MF; Colledge D; Soppe S; Bellocchi MC; Armenia D; Carioti L; Continenza F; Di Carlo D; Saccomandi P; Mirabelli C; Pollicita M; Longo R; Romano S; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Iapadre N; Barlattani A; Bertoli A; Mari T; Pasquazzi C; Missale G; Sarrecchia C; Orecchini E; Michienzi A; Andreoni M; Francioso S; Angelico M; Verheyen J; Ceccherini-Silberstein F; Locarnini S; Perno CF; Svicher V
    Oncotarget; 2017 Feb; 8(9):15704-15715. PubMed ID: 28152517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma.
    Tsai HW; Lin YJ; Wu HC; Chang TT; Wu IC; Cheng PN; Yen CJ; Chan SH; Huang W; Su IJ
    Oncotarget; 2016 May; 7(19):27724-34. PubMed ID: 27027237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis.
    Wang LH; Huang W; Lai MD; Su IJ
    Carcinogenesis; 2012 Feb; 33(2):466-72. PubMed ID: 22159224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
    Liang YJ; Teng W; Chen CL; Sun CP; Teng RD; Huang YH; Liang KH; Chen YW; Lin CC; Su CW; Tao MH; Wu JC
    Hepatology; 2021 Aug; 74(2):641-655. PubMed ID: 33675094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of LHBs with C53 promotes hepatocyte mitotic entry: A novel mechanism for HBV-induced hepatocellular carcinoma.
    Lei Y; Liu H; Yang Y; Wang X; Ren N; Li B; Liu S; Cheng J; Fu X; Zhang J
    Oncol Rep; 2012 Jan; 27(1):151-9. PubMed ID: 21971960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different pre-S deletion patterns and their association with hepatitis B virus genotypes.
    Chen BF
    World J Gastroenterol; 2016 Sep; 22(35):8041-9. PubMed ID: 27672298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B.
    Mathai AM; Alexander J; Kuo FY; Torbenson M; Swanson PE; Yeh MM
    Hum Pathol; 2013 Aug; 44(8):1665-71. PubMed ID: 23574780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-S2 Start Codon Mutation of Hepatitis B Virus Subgenotype B3 Effects on NF-κB Expression and Activation in Huh7 Cell Lines.
    Siburian MD; Suriapranata IM; Wanandi SI
    Viral Immunol; 2018 Jun; 31(5):362-370. PubMed ID: 29652648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
    Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
    Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.